STOXPO
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
STOXPO
No Result
View All Result
Home Healthcare Pharmaceuticals
chemistry-2

Telomir Pharmaceuticals Unveils Groundbreaking Progeria Treatment in Preclinical Study

byLuca Blaumann
January 7, 2025
in Pharmaceuticals, Small-Cap
Reading Time: 3 mins read
Share on TwitterShare on LinkedIn

Novel Therapy Shows Promise in Restoring Lifespan and Addressing Accelerated Aging

Telomir Pharmaceuticals (TELO), a leader in age-reversal science, has announced promising results from a preclinical study of Telomir-1, a potential therapy targeting the accelerated aging associated with progeria. Conducted in collaboration with Nagi Bioscience SA, the study utilized C. elegans (nematode) models to demonstrate that Telomir-1 effectively restores shortened lifespan and normalizes aging processes.

Key Findings from the Study

The study focused on nematodes with a mutation in the wrn-1 gene, analogous to the human gene implicated in Werner Syndrome, a form of progeria. These mutated nematodes showed significantly reduced lifespans compared to normal counterparts. However, treatment with Telomir-1 restored their longevity to levels comparable to non-mutated specimens. The therapy also improved physiological markers such as movement velocity and tail amplitude, extending healthy lifespan alongside overall longevity.

Dr. Laurent Mouchiroud, Co-founder and CSO of Nagi Bioscience, emphasized the therapy’s transformative potential: “These findings underscore Telomir-1’s ability to counter the decline observed in untreated populations, offering new hope for age-related conditions.”

Understanding Progeria and Accelerated Aging

Progeria, or Hutchinson-Gilford Progeria Syndrome, is a rare genetic disorder causing rapid aging in children. Affecting fewer than 400 individuals globally, the condition leads to severe complications, including cardiovascular issues and premature death.

At its core, progeria results from the accumulation of progerin, a defective protein that accelerates telomere shortening and disrupts cellular processes. Telomeres, the protective caps of chromosomes, naturally shorten with age, but this process is dramatically hastened in progeria, causing widespread cellular dysfunction.

Telomir-1: A Novel Approach

Telomir-1 addresses cellular dysfunction by regulating metal imbalances, reducing oxidative stress, and preventing telomere shortening. Key features of the therapy include:

  • Iron Regulation: Mitigating iron overload to reduce oxidative stress and prevent ferroptosis, a form of cell death linked to accelerated aging.
  • Copper Balancing: Addressing copper imbalances to improve organ function and metabolism, targeting conditions like Wilson’s disease.

These mechanisms support cellular health and longevity, making Telomir-1 a promising candidate for addressing progeria and other age-related diseases.

Broader Applications and Future Research

Beyond progeria, Telomir-1 has shown potential in reversing biological aging, improving insulin resistance in Type 2 diabetes, and regulating copper metabolism in Wilson’s disease.

“Our research validates Telomir-1’s ability to tackle aging at its root,” said Erez Aminov, Chairman and CEO of Telomir. “This therapy represents a novel pathway to treating progeria while exploring broader applications in aging-related conditions.”

Telomir is now preparing for in vitro studies using human progeria cell lines, aiming to further establish Telomir-1’s efficacy in restoring cellular health and normalizing aging processes. This breakthrough could pave the way for transformative therapies addressing the fundamental causes of aging.

Read original press release here

You might like this article:Nvidia Unveils AI and Gaming Innovations at CES 2025

Tags: GrowthLongevityMoversNewsStock MarketTELOTelomir Pharmaceuticals
Previous Post

Nvidia Unveils AI and Gaming Innovations at CES 2025

Next Post

Uber and NVIDIA Partner to Accelerate Autonomous Driving with AI-Powered Solutions

Related Posts

trading-chart-2

BitMine Raises $250 Million to Launch One of the Largest Public Ether Treasuries

byLuca Blaumann
June 30, 2025
0

Ethereum-focused strategy attracts top crypto investors as BitMine stock surges on bold treasury pivot BitMine Immersion Technologies (BMNR) has announced...

EXCLUSIVE: MIRA Pharmaceuticals’ Disruptive Path In Neurology And Metabolic Disorders

byLiliana Vida
June 30, 2025
0

CEO Erez Aminov on Breakthrough Drug Candidates, Strategic Acquisitions, and the Vision Behind MIRA’s Innovation-Driven Pipeline MIRA Pharmaceuticals (NASDAQ: MIRA),...

ev-charging-3

Ideal Power Advances Commercialization of B-TRAN® Technology with New EV Industry Order

byLuca Blaumann
June 26, 2025
0

Tier 1 Automotive Supplier to Evaluate B-TRAN® for Next-Generation Solid-State EV Contactor Applications Ideal Power (IPWR), a leading developer of...

Next Post

Uber and NVIDIA Partner to Accelerate Autonomous Driving with AI-Powered Solutions

Latest News

KULR Boosts Bitcoin Holdings to Over 1,000 BTC, Reports 291% Year-to-Date BTC Yield

Delta Reinstates 2025 Profit Outlook, But Summer Travel Outlook Lifts Shares

Uber Rides High on AV Partnerships and Strategic Momentum

Nvidia Becomes First Public Company to Top $4 Trillion in Market Value

Trump Executive Order Deals Blow to U.S. Solar Sector

Based on Your Interest

trading-chart
Large-Cap

IBM Launches Power11 Chips to Boost AI Efficiency and Data Center Reliability

July 8, 2025
bitcoin-1
Bitcoin

KULR Technology Secures $20 Million Bitcoin-Backed Credit Facility from Coinbase

July 8, 2025
semiconductor-7
Large-Cap

Citi Boosts Nvidia Target on Soaring Global AI Demand

July 7, 2025

Recommended

Biotechnology

Regencell Bioscience’s Stock Whipsaws Again Amid 17,000% Surge in 2025

July 7, 2025
Cybersecurity

CrowdStrike Hits Record High After Wedbush Declares It Cybersecurity’s “Gold Standard”

July 3, 2025
Large-Cap

OpenAI Secures 4.5 GW of Data Center Power From Oracle in Record-Breaking Deal

July 3, 2025
Large-Cap

Footwear Stocks Rise After Trump Announces Vietnam Trade Deal

July 2, 2025
Altcoins

Circle Applies for U.S. Trust Bank Charter to Strengthen Stablecoin Strategy

July 1, 2025
Stoxpo

Follow us on social media:

Highlights

  • KULR Boosts Bitcoin Holdings to Over 1,000 BTC, Reports 291% Year-to-Date BTC Yield
  • Delta Reinstates 2025 Profit Outlook, But Summer Travel Outlook Lifts Shares
  • Uber Rides High on AV Partnerships and Strategic Momentum
  • Nvidia Becomes First Public Company to Top $4 Trillion in Market Value
  • Trump Executive Order Deals Blow to U.S. Solar Sector

Category

  • Blog
  • Communication Services
    • Entertainment
    • Internet
    • Telecommunications
  • Companies
    • Large-Cap
    • Mega-Cap
    • Micro-Cap
    • Mid-Cap
    • Small-Cap
  • Consumer Cyclical
    • Auto Manufacturers
    • Casinos & Gambling
    • Ground Transportation
    • Hospitality
      • Casinp
      • Resorts & Lodging
      • Restaurants
      • Travel
        • Airlines
    • Retail
    • Textiles, Apparel & Luxury Goods
  • Consumer Defensive
    • Beverages
    • Discount Stores
    • Distributor
    • Ecommerece
    • Electrical Equipment
    • Foods
    • Household & Personal Products
    • Leisure Products
    • Tobacco
  • Contributions
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Economy
  • Energy
    • Electric
    • Oil & Gas
    • Renewables
  • Financial Services
    • Asset Management
    • Banks
    • Brokerages
    • Credit Services
    • Insurance
  • Healthcare
    • Biotechnology
    • Medical Devices
    • Pharmaceuticals
  • Industrials
    • Aerospace & Defense
    • Construction
    • Industrial Machinery
  • Materials
    • Building Materials
    • Chemicals
    • Gold
    • Mining
    • Silver
    • Steel
  • Q&A's
  • Real Estate
  • Technology
    • Artificial Intelligence
    • Computer Hardware
    • Consumer Electronics
    • Cybersecurity
    • IT Services
    • Semiconductors
    • Software
  • Utilities

Latest News

KULR Boosts Bitcoin Holdings to Over 1,000 BTC, Reports 291% Year-to-Date BTC Yield

July 10, 2025
airplane

Delta Reinstates 2025 Profit Outlook, But Summer Travel Outlook Lifts Shares

July 10, 2025

Uber Rides High on AV Partnerships and Strategic Momentum

July 9, 2025
  • About
  • Privacy Policy
  • Contact

© 2024 All Rights Reserved: STOXPO.

No Result
View All Result
  • Latest News
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Technology
    • Software
    • Semiconductors
  • Crypto
    • Bitcoin
    • Ethereum
    • Altcoins
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions

© 2024 All Rights Reserved: STOXPO.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More

In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information

Accept Cookie Settings
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
  • Always Active
    Necessary
    Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
  • Marketing
    Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
  • Analytics
    Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
  • Preferences
    Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
  • Unclassified
    Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
Cookie Settings

Do you really wish to opt-out?